期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肝细胞肝癌发生的相关分子学机制与研究进展 被引量：1

下载PDF
导出
摘要 肝细胞肝癌（HCC）是与慢性肝炎病毒感染密切相关的恶性肿瘤，其发生率和死亡率分别占全球恶性肿瘤的第5位和第3位，占我国恶性肿瘤的第3位和第2位，在全球每年新增的60余万病例中我国病例占50％以上。根据流行病学调查，我国目前约有9300万乙肝病毒携带者，其中患者98万余人，约有4000万丙肝病毒感染者，其中患者7万余人。
作者 张品南 许杨扬 郑园园
机构地区 浙江省温州市第三人民医院
出处 《浙江临床医学》 2010年第8期893-895,共3页 Zhejiang Clinical Medical Journal
关键词 肝细胞肝癌 分子学机制 肝癌发生 慢性肝炎病毒感染 乙肝病毒携带者 丙肝病毒感染者 恶性肿瘤 流行病学调查
分类号 R735.7 [医药卫生—肿瘤]
  • 相关文献

参考文献18

  • 1Jung JK,Arora P,Pagano JS,et al.Expression of DNA methyltrans-ferase 1 is activated by hepatitis B virus X protein via a regulatory cir?cuit involving the P16NK4a-cyclin D1-CDK4/6-PRbF2Fl Path?way.Cancer Res,2007,67(12):5771 -5778.
  • 2Gao W,Kondo Y,Shen L,et al.Variable DNA methylation Patterns associated with progression of disease in hepatocellular carcinomas.Carcinogenesis,2008,29(10):1901-1910.
  • 3Harder J,Opitz OG,Brabender J,et al.Quantitative promoter methylation analysis of hepatocellular carcinoma,cirrhotie and normal liver.Int J Cancer,2008,122(12):2800-2804.
  • 4Yu J,Tao Q,Cheung KF,et al.Epigenitic identification of ubiquitin carboxyl-terminal hydrolaseLl as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.Hepatology,2008,48(2):508 -518.
  • 5Kondo Y,Shen L,Suzuki S,et al.Alterations of DNA methylation and histone modifications contributeto gene silencing in hepatocellular carcinomas.Hepatol Res,2007,37(11):974 -983.
  • 6Lee JS,Chu IS,Heo J,et al.Classifications and predication of survival in hepatocellular carcinoma by gene expression profiling.Hepatology,2004,40 (3):667 - 676.
  • 7Datta J,Kutay H,Nasser MW,et al.Methylation mediated silencing of microRNA-1 gene and its role in hepatocelluar carcinogenesis.Cancer Res,2008,68(13):5049 - 5058.
  • 8Liocet JM,Chen Y,Wurmbach E,et al.molecular changes from dysplastic module to hepatocellular carcinoma in HCV cirrhosis.Gastroenterology,2006,131 (6):1758 - 1767.
  • 9Wurmbach E,Chen YB,Khitrov G,et al.Genome-vide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.Hepatology,2007,45(4):938 -947.
  • 10Yeh MM,Larson AM,Campbell JS,et al.The expression of transforming growth factor-alpha in cirrhosis,dysplatic nodules,and hepatocellular carcinoma:an immunohistochemical study of 70 cases.Am J Surg Pathol,2007,31 (5):681 -689.

二级参考文献6

共引文献12

同被引文献29

  • 1郭连英,杨泷,施广霞,任含平,沈洁,钱振超.JNK/SAPKs信号转导通路在榄香烯抗肝癌效应中的作用[J].中国肿瘤生物治疗杂志,2005,12(3):202-205. 被引量：8
  • 2李航宇,钟鑫平,隋春阳,孔凡民,董明,张浩,刘金钢.JNK/SAPK信号转导系统在三氧化二砷诱导肝癌细胞凋亡中的作用[J].世界华人消化杂志,2007,15(7):688-693. 被引量：7
  • 3LAI EC, I.AU WY. The continuing challenge of hepatic cancer in Asia [J] .Surgeon, 2005, 3 (3): 210-215.
  • 4HEITMAN J, MOWA NR, HALL MN. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast [.J] . Science, 1991, 253 ( 5022 ) : 905 - 909.
  • 5BAI X, JIANG Y. Key factors in roTOR regulation [J] . Cell Mol Life Sci, 2010 , 67 (2) : 239 -253.
  • 6MENON S, MANNING BD. Common corruption of the mTOR signaling network in human Tumors [ J ] . Oncogene, 2008 , 27 Suppl 2: S43 -51.
  • 7LASITHIOTAKIS KG, SINNBERG TW, SCHITTEK B, et al. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells [ J ] . J Invest Dermatol, 2008 , 128 (8) : 2013 -2023.
  • 8SAHIN F, KANNANGAI R, ADEGBOLA O, et al. mTOR and P70 S6 kinase expression in primary liver neoplasms [ J ] . Clin Cancer Res, 2004, 10 (24): 8421-2845.
  • 9RIZELL M, LINDNER P. Inhibition of mTOR suppresses experimental liver tumours [J] . Anticancer Res, 2005, 25 (2): 789-93.
  • 10GARCi A -MACEIRA P, MATEO J. Silibinin inhibits hypoxia-inducible factor-lalpha and mTOR/pTOS6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer ceils : implications for anticancer therapy [J] . Oncogene, 2009, 28 (3): 313-324.

引证文献1

浙江临床医学
2010年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部